MENU
SPRY
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

ARS Pharmaceuticals (SPRY) Earnings Date & Reports

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U... Show more

A.I. Advisor
published Earnings

SPRY is expected to report earnings to fall 54.76% to -28 cents per share on November 17

ARS Pharmaceuticals SPRY Stock Earnings Reports
Q3'26
Est.
$-0.28
Q2'26
Missed
by $0.13
Q1'26
Missed
by $0.12
Q4'25
Beat
by $0.01
Q3'25
Missed
by $0.06
The last earnings report on August 13 showed earnings per share of -62 cents, missing the estimate of -50 cents. With 597.46K shares outstanding, the current market capitalization sits at 410.72M.